694 results
Page 14 of 35
6-K
EX-99.1
fef9ytik wg
16 Mar 12
Live Filing
12:00am
6-K
EX-99.1
j05vkoclo99ed
14 Mar 12
Teva Announces Launch of Generic Lexapro® in the United States; Awarded 180-Day Period of Marketing Exclusivity
12:00am
6-K
EX-99.1
gxi2m9as 1l
8 Mar 12
Teva Receives FDA Approval for ProAir® HFA (albuterol sulfate) with Dose Counter
12:00am
6-K
EX-99.1
vx9nl7r
8 Mar 12
Teva and OncoGenex Announce Updates to Custirsen Development Program in Advanced Prostate Cancer
12:00am
6-K
EX-99.1
eqr9mbn2r
5 Mar 12
Late Stage Data Demonstrated Long-Term Nasal Symptom Relief and Improvement in Quality of Life
12:00am
6-K
EX-99.1
8n9hh6n
2 Mar 12
Teva Announces Launch of Generic Prometrium® Capsules in the United States
12:00am
6-K
j6xly
15 Feb 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
EX-99.1
p9e7g8
3 Jan 12
Live Filing
12:00am
6-K
EX-99.1
93tmo
3 Jan 12
Teva Announces Management Succession
12:00am
6-K
EX-99.1
ql23pgq ctfby
21 Dec 11
Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68
12:00am
F-3ASR
3lnlc5
9 Dec 11
Automatic shelf registration (foreign)
12:00am
6-K
EX-99.1
2r4ji3roxv
2 Dec 11
Live Filing
12:00am
6-K
EX-99.1
evquz7
1 Dec 11
Live Filing
12:00am
6-K
EX-99.1
w4wgm416sbli62vg
8 Nov 11
Teva Announces Pricing of $5,000,000,000 of Senior Notes
12:00am
424B5
3qu115nbcb
8 Nov 11
Prospectus supplement for primary offering
12:00am
424B5
mso6k6
7 Nov 11
Prospectus supplement for primary offering
12:00am
6-K
vqwdzjd naq6qcf1qm
2 Nov 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
h4tjm sriw3pcn89umhq
2 Nov 11
Current report (foreign)
12:00am
6-K
vr8l y47u6fm
2 Nov 11
Teva Pharmaceutical Industries Limited 6-K
12:00am